Human Molecular Genetics, 2001, Vol. 10, No. 25 2851-2859
© 2001 Oxford University Press
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C
1Dubowitz Neuromuscular Centre, Department of Paediatrics, Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, London, UK, 2Department of Cytomorphology, University of Cagliari, Italy, 3Department of Human Anatomy and Genetics, University of Oxford, UK, 4Department of Paediatrics and Paediatric Neurology, University of Essen, Germany, 5Department of Biochemistry and Genetics, University of Newcastle upon Tyne, UK, 6Department of Biological Sciences, University of Durham, UK, 7University Bern Inselspital, CH-3010 Bern, Switzerland, 8Childrens Hospital of New Jersey, Newark, USA, 9Inserm U 523, Institut De Myologie, Groupe Hospitalier Pitie-Salpetriere, Paris, France and 10Department of Histopathology, Robert Jones and Agnes Hunt, Orthopaedic Hospital, Oswestry, UK
The limb girdle and congenital muscular dystrophies (LGMD and CMD) are characterized by skeletal muscle weakness and dystrophic muscle changes. The onset of symptoms in CMD is within the first few months of life, whereas in LGMD they can occur in late childhood, adolescence or adult life. We have recently demonstrated that the fukutin-related protein gene (FKRP) is mutated in a severe form of CMD (MDC1C), characterized by the inability to walk, leg muscle hypertrophy and a secondary deficiency of laminin
2 and
-dystroglycan. Both MDC1C and LGMD2I map to an identical region on chromosome 19q13.3. To investigate whether these are allelic disorders, we undertook mutation analysis of FKRP in 25 potential LGMD2I families, including some with a severe and early onset phenotype. Mutations were identified in individuals from 17 families. A variable reduction of
-dystroglycan expression was observed in the skeletal muscle biopsy of all individuals studied. In addition, several cases showed a deficiency of laminin
2 either by immunocytochemistry or western blotting. Unexpectedly, affected individuals from 15 families had an identical C826A (Leu276Ileu) mutation, including five that were homozygous for this change. Linkage analysis identified at least two possible haplotypes in linkage disequilibrium with this mutation. Patients with the C826A change had the clinically less severe LGMD2I phenotype, suggesting that this is a less disruptive FKRP mutation than those found in MDC1C. The spectrum of LGMD2I phenotypes ranged from infants with an early presentation and a Duchenne-like disease course including cardiomyopathy, to milder phenotypes compatible with a favourable long-term outcome.
+ To whom correspondence should be addressed at: The Dubowtz Neuromuscular Unit, Division of Paediatrics, Obstetrics and Gynaecology, Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. Tel: +44 20 8383 3295; Fax: +44 20 8740 8281; Email: f.muntoni@ic.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Mercuri, S. Messina, C. Bruno, M. Mora, E. Pegoraro, G. P. Comi, A. D'Amico, C. Aiello, R. Biancheri, A. Berardinelli, et al. Congenital muscular dystrophies with defective glycosylation of dystroglycan: A population study Neurology, May 26, 2009; 72(21): 1802 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanagawa, A. Nishimoto, T. Chiyonobu, S. Takeda, Y. Miyagoe-Suzuki, F. Wang, N. Fujikake, M. Taniguchi, Z. Lu, M. Tachikawa, et al. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy Hum. Mol. Genet., February 15, 2009; 18(4): 621 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Ackroyd, L. Skordis, M. Kaluarachchi, J. Godwin, S. Prior, M. Fidanboylu, R. J. Piercy, F. Muntoni, and S. C. Brown Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies Brain, February 1, 2009; 132(2): 439 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. U. Yamamoto, F. J. Velloso, B. L. Lima, L. L.Q. Fogaca, F. de Paula, N. M. Vieira, M. Zatz, and M. Vainzof Muscle Protein Alterations in LGMD2I Patients With Different Mutations in the Fukutin-related Protein Gene J. Histochem. Cytochem., November 1, 2008; 56(11): 995 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kesari, M. Fukuda, S. Knoblach, R. Bashir, G. A. Nader, D. Rao, K. Nagaraju, and E. P. Hoffman Dysferlin Deficiency Shows Compensatory Induction of Rab27A/Slp2a That May Contribute to Inflammatory Onset Am. J. Pathol., November 1, 2008; 173(5): 1476 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Peat, J. M. Smith, A. G. Compton, N. L. Baker, R. A. Pace, D. J. Burkin, S. J. Kaufman, S. R. Lamande, and K. N. North Diagnosis and etiology of congenital muscular dystrophy Neurology, July 29, 2008; 71(5): 312 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Thornhill, D. Bassett, H. Lochmuller, K. Bushby, and V. Straub Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP) Brain, June 1, 2008; 131(6): 1551 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.P. Beynon and S.G. Ray Cardiac involvement in muscular dystrophies QJM, May 1, 2008; 101(5): 337 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Clement, C. Godfrey, J. Tan, M. Brockington, S. Torelli, L. Feng, S. C. Brown, C. Jimenez-Mallebrera, C. A. Sewry, C. Longman, et al. Mild POMGnT1 Mutations Underlie a Novel Limb-Girdle Muscular Dystrophy Variant Arch Neurol, January 1, 2008; 65(1): 137 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Godfrey, E. Clement, R. Mein, M. Brockington, J. Smith, B. Talim, V. Straub, S. Robb, R. Quinlivan, L. Feng, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan Brain, October 1, 2007; 130(10): 2725 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Beedle, P. M. Nienaber, and K. P. Campbell Fukutin-related Protein Associates with the Sarcolemmal Dystrophin-Glycoprotein Complex J. Biol. Chem., June 8, 2007; 282(23): 16713 - 16717. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Wilkie and E. C. Schirmer Guilt by Association: The Nuclear Envelope Proteome and Disease Mol. Cell. Proteomics, October 1, 2006; 5(10): 1865 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Amico, A. Tessa, C. Bruno, S. Petrini, R. Biancheri, M. Pane, M. Pedemonte, E. Ricci, A. Falace, A. Rossi, et al. Expanding the clinical spectrum of POMT1 phenotype Neurology, May 23, 2006; 66(10): 1564 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taniguchi, H. Kurahashi, S. Noguchi, T. Fukudome, T. Okinaga, T. Tsukahara, Y. Tajima, K. Ozono, I. Nishino, I. Nonaka, et al. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in {alpha}-dystroglycanopathies Hum. Mol. Genet., April 15, 2006; 15(8): 1279 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wopereis, D. J. Lefeber, E. Morava, and R. A. Wevers Mechanisms in Protein O-Glycan Biosynthesis and Clinical and Molecular Aspects of Protein O-Glycan Biosynthesis Defects: A Review Clin. Chem., April 1, 2006; 52(4): 574 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mercuri, H. Topaloglu, M. Brockington, A. Berardinelli, A. Pichiecchio, F. Santorelli, M. Rutherford, B. Talim, E. Ricci, T. Voit, et al. Spectrum of Brain Changes in Patients With Congenital Muscular Dystrophy and FKRP Gene Mutations Arch Neurol, February 1, 2006; 63(2): 251 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Barresi and K. P. Campbell Dystroglycan: from biosynthesis to pathogenesis of human disease J. Cell Sci., January 15, 2006; 119(2): 199 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Boito, P. Melacini, A. Vianello, P. Prandini, B. F. Gavassini, A. Bagattin, G. Siciliano, C. Angelini, and E. Pegoraro Clinical and Molecular Characterization of Patients With Limb-Girdle Muscular Dystrophy Type 2I Arch Neurol, December 1, 2005; 62(12): 1894 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Piluso, L Politano, S Aurino, M Fanin, E Ricci, V M Ventriglia, A Belsito, A Totaro, V Saccone, H Topaloglu, et al. Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes J. Med. Genet., September 1, 2005; 42(9): 686 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schwartz, J. M. Hertz, M. L. Sveen, and J. Vissing LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype Neurology, May 10, 2005; 64(9): 1635 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brockington, S. Torelli, P. Prandini, C. Boito, N. F. Dolatshad, C. Longman, S. C. Brown, and F. Muntoni Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy Hum. Mol. Genet., March 1, 2005; 14(5): 657 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Esapa, R.A. J. McIlhinney, and D. J. Blake Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells Hum. Mol. Genet., January 15, 2005; 14(2): 295 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsumoto, S. Noguchi, K. Sugie, M. Ogawa, K. Murayama, Y. K. Hayashi, and I. Nishino Subcellular Localization of Fukutin and Fukutin-Related Protein in Muscle Cells J. Biochem., June 1, 2004; 135(6): 709 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Beltran-Valero de Bernabe, T Voit, C Longman, A Steinbrecher, V Straub, Y Yuva, R Herrmann, J Sperner, C Korenke, C Diesen, et al. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome J. Med. Genet., May 1, 2004; 41(5): e61 - e61. [Full Text] [PDF] |
||||
![]() |
K. A. Lapidos, R. Kakkar, and E. M. McNally The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma Circ. Res., April 30, 2004; 94(8): 1023 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M C Walter, J A Petersen, R Stucka, D Fischer, R Schroder, M Vorgerd, A Schroers, H Schreiber, C O Hanemann, U Knirsch, et al. FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients J. Med. Genet., April 1, 2004; 41(4): e50 - e50. [Full Text] [PDF] |
||||
![]() |
J. Kirschner and C. G. Bonnemann The Congenital and Limb-Girdle Muscular Dystrophies: Sharpening the Focus, Blurring the Boundaries Arch Neurol, February 1, 2004; 61(2): 189 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Brown, S. Torelli, M. Brockington, Y. Yuva, C. Jimenez, L. Feng, L. Anderson, I. Ugo, S. Kroger, K. Bushby, et al. Abnormalities in {alpha}-Dystroglycan Expression in MDC1C and LGMD2I Muscular Dystrophies Am. J. Pathol., February 1, 2004; 164(2): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Longman, M. Brockington, S. Torelli, C. Jimenez-Mallebrera, C. Kennedy, N. Khalil, L. Feng, R. K. Saran, T. Voit, L. Merlini, et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of {alpha}-dystroglycan Hum. Mol. Genet., November 1, 2003; 12(21): 2853 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Grewal and J. E. Hewitt Glycosylation defects: a new mechanism for muscular dystrophy? Hum. Mol. Genet., October 15, 2003; 12(90002): R259 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Martin and H. H. Freeze Glycobiology of neuromuscular disorders Glycobiology, August 1, 2003; 13(8): 67R - 75R. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Michele and K. P. Campbell Dystrophin-Glycoprotein Complex: Post-translational Processing and Dystroglycan Function J. Biol. Chem., April 25, 2003; 278(18): 15457 - 15460. [Full Text] [PDF] |
||||
![]() |
M. Poppe, L. Cree, J. Bourke, M. Eagle, L.V.B. Anderson, D. Birchall, M. Brockington, M. Buddles, M. Busby, F. Muntoni, et al. The phenotype of limb-girdle muscular dystrophy type 2I Neurology, April 22, 2003; 60(8): 1246 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Driss, S. Noguchi, R. Amouri, M. Kefi, T. Sasaki, K. Sugie, S. Souilem, Y.K. Hayashi, N. Shimizu, S. Minoshima, et al. Fukutin-related protein gene mutated in the original kindred limb-girdle MD 2I Neurology, April 22, 2003; 60(8): 1341 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Topaloglu, M. Brockington, Y. Yuva, B. Talim, G. Haliloglu, D. Blake, S. Torelli, S.C. Brown, and F. Muntoni FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts Neurology, March 25, 2003; 60(6): 988 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Muntoni Cardiac Complications of Childhood Myopathies J Child Neurol, March 1, 2003; 18(3): 191 - 202. [Abstract] [PDF] |
||||
![]() |
C. T. Esapa, M. A. Benson, J. E. Schroder, E. Martin-Rendon, M. Brockington, S. C. Brown, F. Muntoni, S. Kroger, and D. J. Blake Functional requirements for fukutin-related protein in the Golgi apparatus Hum. Mol. Genet., December 15, 2002; 11(26): 3319 - 3331. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Karpati and P. Holland Sweetening the pot in muscle: Genetic defects of protein glycosylation causing muscle disease Neurology, December 10, 2002; 59(11): 1674 - 1676. [Full Text] [PDF] |
||||
![]() |
M. M Reilly and M. G Hanna Genetic neuromuscular disease J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(90002): ii12 - 21. [Full Text] [PDF] |
||||
![]() |
P. J. Holzfeind, P. K. Grewal, H. A. Reitsamer, J. Kechvar, H. Lassmann, H. Hoeger, J. E. Hewitt, and R. E. Bittner Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Largemyd mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders Hum. Mol. Genet., October 2, 2002; 11(21): 2673 - 2687. [Abstract] [Full Text] [PDF] |
||||
















